Otros idiomas Heart Test Laboratories, Inc.

Acciones

HSCS

US42254E3027

Tiempo real estimado Cboe BZX Otros sitios de cotización 19:12:55 10/06/2024			Varia. Cinco días.	Varia. 1 de enero.
5,725 ^USD	-1,80 %		-0,53 %	-66,90 %

24/04	HeartSciences anuncia la concesión de una patente fundamental por la Oficina Europea de Patentes que cubre la evaluación de la función diastólica del corazón mediante AI-ECG	CI
26/03	HeartSciences anuncia la presentación en el podio del Congreso Mundial de Anestesiólogos de la utilidad del ECG de ondas MyoVista® para la detección de la disfunción diastólica del ventrículo izquierdo en pacientes preoperatorios	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

HeartSciences Regains Compliance with Nasdaq Listing Requirements	04/06
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio	20/05
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	24/04
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	24/04
HeartSciences to Present at the LD Micro Invitational XIV Conference	02/04
HeartSciences to Present at the LD Micro Invitational XIV Conference	02/04
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	26/03
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	26/03
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results	14/03
Heart Test Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	14/03
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes	12/03
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology	06/03
HeartSciences Adds Key Advisor to its Scientific Advisory Board	26/02
HeartSciences Adds Key Advisor to its Scientific Advisory Board	26/02
Heart Test Laboratories, Inc. Appoints Partho P. Sengupta to Its Scientific Advisory Board	26/02
HeartSciences Expands its Scientific Advisory Board	12/02
Heart Test Laboratories, Inc. Appoints Jordan B. Strom to Its Scientific Advisory Board	12/02
HeartSciences Appoints New Scientific Advisory Board Member	01/02
HeartSciences Appoints New Scientific Advisory Board Member	01/02
HeartSciences Appoints Benjamin Glicksberg to its Scientific Advisory Board	01/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Heart Test Laboratories, Inc.

Acciones

HSCS

US42254E3027

Otros idiomas

Filtros